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Abstract
Background: Choroid plexus tumors (CPTs) are rare neoplasms accounting for 
only 0.3–0.6% of all brain tumors in adults and 2–5% in children. The World Health 
Organization  (WHO)  classification describes  three histological  grades:  grade  I 
is choroid plexus papilloma (CPP), grade  II  is atypical papilloma, and grade  III 
is the malignant form of carcinoma. In adults, CPTs rarely have a supratentorial 
localization.
Case Description: Here we  report  a  very  rare  case  of  an  intraparenchymal 
parietal CPP with a rapid histological transition from grade I to grade III WHO in a 
67‑year‑old man, in <7 months.
Conclusion: Because of the rarity of these oncotypes, descriptions of each new 
case are useful, mostly to consider this diagnostic entity in extraventricular brain 
tumors of adults, despite an unusual location.
Key Words: Choroid plexus atypical papilloma, choroid plexus carcinoma, choroid 
plexus papillomas, malignant progression, World Health Organization classification
BACKGROUND
Choroid plexus tumors (CPTs) are rare intracranial 
neoplasms that derive from the choroid plexus epithelium 
of ventricular system. CPTs account for only 0.3–0.6% 
of all brain tumors in adults and 2–5% in children.[1‑3,19] 
The World Health Organization (WHO) classification 
describes three histological grades: grade I is choroid 
plexus papilloma (CPP), grade II is atypical papilloma, 
and grade III is the malignant form of carcinoma.[5]
CPTs are of neuroectodermal origin, arising from 
epithelial cells of the choroid plexus and are found 
mostly in the lateral and fourth ventricles, and less 
commonly in the third ventricle.[10] CPTs occasionally 
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appear as an extraventricular intraparenchymal mass 
unrelated to the ventricular system, which causes 
great difficulties in preoperative diagnosis and in the 
surgical strategy: the pineal region, brainstem, sellar or 
suprasellar region, cerebellum, and cerebral hemisphere. 
Their etiopathogenesis is unclear at present, although 
several studies address and reveal new insight.[12,10,19] 
Approximately, 25% of choroid plexus neoplasms are 
malignant, and malignant degeneration from CPP to 
carcinoma has been rarely described.[4,17]
We report a very rare case of an intraparenchymal CPP 
with a documented rapid transition from benign to 
malignant histology.
CASE DESCRIPTION
A 67‑year‑old right‑handed man presented to our 
department with a 4‑month history of progressively 
worsening headaches and a 2‑week history of slurred 
speech and lower limb weakness. On physical 
examination, the patient was alert and oriented but with 
a transcortical sensory aphasia associated with ideomotor 
apraxia and episodes of spatial disorientation. No other 
focal motor, sensory, or cerebellar abnormalities were 
detected, and the remainder of the physical examination 
was unremarkable. He was afebrile and had normal vital 
signs and normal findings of routine laboratory studies.
A computed tomography (CT) scan of the head 
showed a purely cystic mixed density parietal mass 
on left hemisphere. A contrast‑enhanced magnetic 
resonance imaging (MRI) showed a minimally 
enhancing cyst wall, full of fluid, without a solid nodular 
component [Figure 1].
A left parietal craniotomy was performed. After the dura was 
opened, most of the cyst was removed and five soft‑tissue 
samples specimens were sent for pathological analysis.
Feeding vessels were found deep near the area of the 
ventricular ependyma, but the ependyma of the ventricle 
was not breached during the operation. A partial excision 
of the cyst was performed, being the lesion in full 
eloquent area.
An autologous fibrin glue was used to enhance 
hemostasis and dural sealing.[6,14,15] The patient 
tolerated the procedure well, and there were no 
intraoperative complications. All the examined 
tissues pointed a histologic diagnosis of CPP (WHO 
grade I). We performed a CT scan in the immediate 
postoperative period so as to rule out surgical 
complications (hemorrhage, ischemia) [Figure 2]. On the 
basis of a partial removal of the lesion and the known 
histological diagnosis of grade I, after a multidisciplinary 
assessment, an adjuvant therapy was ruled out and we 
programmed an enhanced examination (CT to MRI) in 
follow‑up after 6 months [Figure 3]. The patient did not 
follow any oncological treatment.
After 7 months the patient developed ataxia, dizziness, 
vomit, and worsening headache. Imaging showed 
significant regrowth of the known residual parietal 
tumor and a new cystic lesion in the cerebellar vermis 
and left fronto‑basal supratentorial region [Figure 3]. 
He underwent a midline suboccipital craniotomy and 
macroscopic resection of tumor. Histology on this 
occasion showed, after only 7 months, a choroid plexus 
carcinoma (CPC) of WHO grade III. The postoperative 
course was uneventful and was referred for consideration 
of adjuvant radiotherapy. The patient died after 6 months.
Pathology
Gross examination of the fresh tumor specimen was 
performed on all available pathological samples (net 
weight of all the specimens: 5.5 g of size 4–12 mm). 
Histological diagnosis was assessed according to the 
WHO criteria for CPTs. CPP was composed of a delicate 
Figure 1: First preoperative MRI shows a cystic plexus papilloma 
in the left parietal region. An enhanced ring can be visualized after 
gadolinium. Histological diagnosis revealed a CPP grade I WHO
Figure 2: Post operative CT scan showed the partial removal of the 
extra ventricular cystic lesion
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and vascularized connective tissue frond covered by a 
single papillary layer of uniform cuboidal to columnar 
epithelial cells with round or ovally, basally situated 
monomorphic nuclei. Mitotic activity was extremely 
low (<1 mitose per 10 hpfs). Brain invasion, increased 
cellular density, necrosis, and nuclear pleomorphism 
were absent. Immunohistochemically, CPP expressed 
cytokeratins. CK7/CK20 combination was CK7‑positive 
and CK20‑negative. Glial fibrillary acid protein (GFAP) 
was focally present. Benign CPP (WHO grade I°) was 
diagnosed.
The specimens from the second surgical procedure after 
7 months were significant for multiple fragments of 
tan‑pink, soft, and friable tissue collectively weighing 
10.5 g and measuring 3 × 2, 5 × 2 cm. The tissue 
was fixed in 10% formalin and processed for paraffin 
embedding. The paraffin blocks were sectioned at 
5‑µm intervals and then stained with hematoxylin 
and eosin for microscopic examination. Histologically, 
malignant progression of CPP was reported. The tumor 
showed frank signs of malignancy. According to the 
WHO criteria, the surgical specimens showed frequent 
mitoses (>5 per 10 randomly selected hpfs), increased 
cellular density, nuclear pleomorphism, blurring of 
the papillary pattern with poorly structured sheets of 
tumor cells, and necrotic areas. The tumor strongly 
immunostained for cytokeratins and it was focally 
positive for GFAP. Immunohistochemical analysis of 
tissue proliferation was carried out using a monoclonal 
antibody against Ki67 (MIB‑1, 1:100; DAKO) using 
the avidin–biotin method on an automated staining 
system. The differential diagnosis included papillary 
anaplastic ependymoma and metastatic carcinoma. 
Because the recurrence was characterized by frank signs 
of malignancy, according to the current WHO criteria, a 
diagnosis of CPC (WHO grade III) was made [Figure 4].
DISCUSSION
Here, we report a very rare case of an intraparenchymal 
CPP with an early transition from grade I to grade III 
WHO in <7 months. Histological grading is recognized 
as an important prognostic factor in CPTs and also 
affects the decision toward adjuvant radiotherapy and 
chemotherapy.
In contrast to benign CPPs (WHO grade I), CPCs (WHO 
grade III) are characterized by frank signs of malignancy 
with frequent mitoses, nuclear pleomorphism, increased 
cellular density, blurring of the papillary growth pattern, 
and necrosis. The distinction between CPP versus CPC 
has not been always clear and some tumors showed 
only one or few histological features of malignancy as 
pleomorphism, increased mitotic activity, or invasion. 
Those tumors have been retrospectively termed atypical 
and classified in WHO grading as II.[7]
A study by Jeibmann et al. documented a series of 
124 previously diagnosed CPPs, whose 15% were 
atypical. Author suggested that previous documented 
transition from benign to malignant histology might be 
overestimated, being extremely rare, instead of a more 
common evolution from grade II to the malignant form.[8,9]
In our case the first specimen revealed an extremely low 
mitotic activity (<1 mitose per 10 hpfs), absence of brain 
invasion, increased cellular density, necrosis, and nuclear 
pleomorphism. Immunohistochemically, there were no 
signs of atopy or malignancy so that a benign CPP (grade 
I WHO) was diagnosed.
After 7 months a new specimen in another surgical 
location revealed frank signs of malignancy. Frequent 
Figure 4: (a) Photomicrograph showing benign features of the 
CPP [hematoxylin and eosin (H and E) original magnification ×200] 
in the sample of the first surgical procedure. (b) Photomicrograph 
showing frank signs of malignancy of CPC (H and E original 
magnification  ×100)  in  the  sample  of  the  second  surgical 




Figure 3: A new MRI, after 7 months, showed a new cystic lesion 
in the cerebellar vermis with an eccentric nodule, in the temporal 
lobe and a recurrent multiloculated lesion in the left parietal region. 
Histological diagnosis was CPC grade III WHO
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mitoses (>5 per 10 randomly selected hpfs), increased 
cellular density, nuclear pleomorphism, blurring of 
the papillary pattern with poorly structured sheets 
of tumor cells, and necrotic areas were documented. 
Immunohistochemical analysis revealed a high Ki67. So, a 
diagnosis of CPC (WHO grade III) was made.
To the best of our knowledge, this is the first reported 
case of a CPP arising in an extraventricular and 
extrachoroidal location which recurred, turning directly in 
malignant histology in few months. As known, in adults, 
CPT originates primarily in the fourth ventricle and only 
very rarely a localization dissociates to the ventricles or 
the choroid plexus.
Several theories have been proposed to explain the 
reasons why these lesions originated in such unusual 
locations. These lesions might arise from the embryonic 
residuals of ectopic secretory choroid plexus epithelium 
or, according another theory, ependymal tissue might 
become segregated during the development of the brain. 
Many ectopic CPTs are in proximity to the ventricular 
system, therefore these lesions possibly might arise within 
the nearby normal choroid plexus and be separated 
from it later as the tumor evolves. However, the exact 
etiopathogenetic mechanism remains unclear.[16,19]
In our case an attachment to the normal choroid plexus 
could not be identified at neuroimaging and the left 
lateral ventricle was effaced but not seemed involved 
with the tumor. Also after 6 months, following the rapid 
malignant evolution of the tumor, there was not an 
involvement of the ventricular area. Besides this, during 
the first surgical procedure, feeding vessels were found 
deep near the area of the ventricular ependyma, but the 
ependyma of the ventricle was not breached during the 
operation, looking as an intact and “healthy” layer.
According to our literature review only 9 cases of 
extraventricular supratentorial CPTs have been described 
in the literature: two pediatric cases with a CPT grade 
III, while the other reports have been described in adult 
patients (1 carcinoma, 2 atypical, 3 benign papillomas, 
and another case not specified).[4,5,13,20]
Malignant progression from papilloma to carcinoma 
is rare. Eight patients have been described in the 
literature to our knowledge. Jeibmann et al. reviewed 
these patients and stated that at least four are probably 
atypical papilloma recurring rather than a progression 
to carcinoma. Thus, the true incidence of malignant 
progression of CPP to CPC may be overestimated.[5,8,9]
CPPs are generally benign tumors, with reported 5‑year 
overall survival (OS) rates of 90–100% and it is widely 
accepted that their complete excision is curative. 
Recurrence of CPP after gross total excision is reported, 
but uncommon. Jeibmann et al. found a recurrence 
rate of 6% for benign CPP and 29% for atypical CPP. 
Metastases of benign CPP are also rare and a review 
by Jinhu et al. identified only 14 well‑documented 
patients.[8‑10]
In our case, we performed a subtotal removal of the 
tumor for saving the near eloquent area. The situation 
is different for CPCs. CPCs carry a correspondingly 
worse prognosis; reported 5‑year OS rates range 
from 26 to 41%.[8,11,18,21]
The present case emphasizes the importance of 
considering this diagnostic entity in an extraventricular 
brain tumor of adults despite an unusual location. We 
think that a closer neuroimaging follow‑up might be 
advisable, although a diagnosis of grade I, being this 
hystotype seldom, also if very rarely, characterized by 
rapid malignant progression.
CONCLUSION
CPC is a rare diagnosis in adults, mostly if extraventricular. 
To the best of our knowledge, this is the first reported case 
of a CPP arising in an extraventricular and extrachroidal 
location which recurred, turning directly into malignant 
histology in few months. Nowadays, the natural history of 
this neoplasm is unknown. An improved understanding 
of the pathogenesis of these tumors will help clinicians in 
future diagnosis and treatment.
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